Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
Clinical GERD management relies on PPIs like omeprazole and esomeprazole to reduce gastric acid secretion by 90–95%. These drugs prevent further erosion but don't actively promote tissue healing. A limitation evident in patients …
Before selecting a peptide, compare supplier-provided documentation against these benchmarks. A certificate of analysis (CoA) without HPLC chromatogram data, mass spectrometry confirmation, and endotoxin testing is not a quality …
Palmitoyl Pentapeptide-4 (Matrixyl) TGF-β pathway activation → collagen synthesis 4–8% Lyophilized at −20°C; reconstituted at 2–8°C for ≤28 days 30–40% wrinkle depth reduction at 90 days Photoaging, fine lines, loss of dermal den…
Before selecting a peptide for joint mobility protocols, map the biological question to the mechanism. A peptide effective for angiogenesis won't necessarily modulate inflammatory cytokines, and vice versa. BPC-157 Upregulates VE…
Understanding how research peptides differ in mechanism, administration, and evidence base helps researchers and clinicians select compounds aligned with specific study objectives or patient profiles. BPC-157 NF-κB inhibition, an…
BPC-157 VEGF upregulation, fibroblast migration, angiogenesis at injury site 250–500 mcg SC twice daily 4–6 weeks (collagen density) Moderate (indirectly through vascularization) Best for acute injuries and microtear repair. Addr…
The evidence base for peptide-based memory enhancement spans three tiers: in vitro receptor binding studies, animal behavioural models, and human clinical trials. Most compounds marketed as cognitive enhancers never progress beyo…
BPC-157 (pentadecapeptide) Angiogenesis and epithelial proliferation VEGF receptor-2 activation, NO synthase stabilization Mucosal healing models, barrier reconstitution studies 10 mcg/kg intraperitoneally Histological damage sco…
KPV NF-κB inhibition in mast cells Anti-inflammatory Preclinical + case reports Topical Strongest evidence for erythema reduction; requires permeation enhancer BPC-157 Vascular stabilization, endothelial repair Angiogenesis modul…
Before selecting peptides for a research protocol, understanding their distinct mechanisms, dosing requirements, and evidence base is essential. BPC-157 Angiogenesis, mitochondrial stabilisation, oxidative stress reduction 10 mcg…
Semax BDNF upregulation via melanocortin receptor binding Human RCTs in healthy adults 600mcg intranasal 2× daily, 14–28 days Intranasal (olfactory pathway) Strongest evidence for near-term memory retention improvement in cogniti…
Before writing this table, here's what it shows: the only two peptides with documented circadian-relevant mechanisms (Epitalon and DSIP) compared against commonly marketed alternatives that lack circadian specificity. The 'Profes…
BPC-157 eNOS stabilization, VEGF upregulation, inflammatory cytokine suppression Acute (0–72 hours) 10 μg/kg Intraperitoneal BBB permeability, lesion volume, motor recovery Best for focal injuries with prominent vascular disrupti…
BPC-157 VEGF upregulation, angiogenesis, nitric oxide signaling 34% increase in nerve conduction velocity in diabetic rat models (12 weeks) Subcutaneous injection Strongest vascular repair evidence; most studied in peripheral ner…
Semax ACTH analog → NGF modulation → BDNF mRNA upregulation via CREB 6–12 hours 24–48 hours High (intranasal bypasses BBB via olfactory pathway) 0.3–0.6 mg/kg subcutaneous or intranasal Best for sustained transcription-based BDNF…
BPC-157 VEGFR2 upregulation → angiogenesis, mucosal blood flow restoration Ethanol-induced, ischemia-reperfusion injury 10–50 mcg/kg IP or oral daily for 7–14 days Minimal effect in NSAID models where vascular injury is secondary…
GLP-1 Agonists (Semaglutide, Tirzepatide) Incretin receptor activation → insulin secretion, gastric emptying delay Hyperinsulinemia, androgen excess Strong clinical translation. Phase 3 data in PCOS populations Best for insulin-a…
Semax BDNF/NGF upregulation 2–4 hours (acute); 7–10 days (peak) Working memory, verbal fluency, pattern recognition Intranasal spray Most reproducible human data. Russian trials show 15–25% improvement on attention tasks. Require…
MOTS-c Mitochondrial biogenesis upregulation via PGC-1alpha activation Complex I function, ROS reduction Intranasal, intraperitoneal 5–15 mg/kg IP 3×/week Reduced ROS, improved mitochondrial respiration in aged brain tissue (USC …
Semax BDNF upregulation via TrkB activation Synaptic plasticity, dendritic spine formation 10–100 μM (in vitro), 50–500 μg/kg (in vivo) Stable in PBS for 7 days at 4°C; degrades rapidly above pH 8.0 Best choice for studying synap…